BamSEC and AlphaSense Join Forces
Learn More

Edwards Lifesciences Corporation

NYSE: EW    
Share price (12/20/24): $74.81    
Market cap (12/20/24): $44.1 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4
from S-8 14 pages Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program
12/34/56
EX-4.2
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.2
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.1
from 10-K 4 pages Description of Capital Stock
12/34/56
EX-4.2
from 8-K 24 pages Edwards Lifesciences Corporation as Issuer Second Supplemental Indenture Dated as of June 15, 2018 to Indenture Dated as of September 6, 2013 Wells Fargo Bank, National Association as Trustee 4.300% Senior Notes Due 2028
12/34/56
EX-4.1
from 8-K 21 pages Edwards Lifesciences Corporation as Issuer First Supplemental Indenture Dated as of October 3, 2013 to Indenture Dated as of September 6, 2013 Wells Fargo Bank, National Association as Trustee 2.875% Senior Notes Due 2018
12/34/56
EX-4.5
from S-3ASR 53 pages Edwards Lifesciences Corporation Indenture Dated as of September 6, 2013 Wells Fargo Bank, National Association Trustee
12/34/56
EX-4.4
from S-3 73 pages Edwards Lifesciences Corporation,
12/34/56
EX-4.3
from S-3 73 pages Edwards Lifesciences Corporation,
12/34/56
EX-4.3
from 10-Q ~50 pages Edwards Lifesciences Corporation and Equiserve Trust Company, N.A. as Rights Agent Rights Agreement Dated as of March 31, 2000
12/34/56
EX-4.2
from 10-Q >50 pages Edwards Lifesciences Corporation, as Issuer Jpmorgan Chase Bank, as Trustee Up to $150,000,000 Aggregate Principal Amount of 3.875% Convertible Senior Debentures Due 2033 Indenture Dated as of May 9, 2003
12/34/56
EX-4.1
from 10-Q ~10 pages For Purposes of Sections 1272, 1273 and 1275 of the Internal Revenue Code of 1986, as Amended, This Security Is Being Issued With Original Issue Discount and the Issue Date of This Security Is May 9, 2003. in Addition, This Security Is Subject to United States Federal Income Tax Regulations Governing Contingent Payment Debt Instruments. for Purposes of Sections 1272, 1273 and 1275 of the Internal Revenue Code, the Issue Price of Each Security Is $1,000 Per $1,000 of Principal Amount and the Comparable Yield Is 4.85%, Compounded Semiannually (Which Will Be Treated as the Yield to Maturity for United States Federal Income Tax Purposes)
12/34/56
EX-4.6
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.5
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.4
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4
from SC 13D ~10 pages Indenture or similar
12/34/56
EX-4.4
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.3
from S-8 ~50 pages 401(k) Savings and Investment Plan
12/34/56
EX-4.1
from 10-12B/A 1 page Specimen Form of Common Stock Cert.
12/34/56
EX-4.6
from S-8 ~10 pages Non-Employee Direc. & CONS.STOCK Incentive Program
12/34/56